Co-Upregulation of 14-3-3ζ and P-Akt is Associated with Oncogenesis and Recurrence of Hepatocellular Carcinoma | Zendy

Yufu Tang | Zendy; Ruoyu Wang | Zendy; Yibing Zhang | Zendy; Shenhui Lin | Zendy; Na Qiao | Zendy; Zhongyi Sun | Zendy; Shuqun Cheng | Zendy; Wenping Zhou | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Co-Upregulation of 14-3-3ζ and P-Akt is Associated with Oncogenesis and Recurrence of Hepatocellular Carcinoma

Author(s) -

Yufu Tang,

Ruoyu Wang,

Yibing Zhang,

Shenhui Lin,

Na Qiao,

Zhongyi Sun,

Shuqun Cheng,

Wenping Zhou

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000487351

Subject(s) - hepatocellular carcinoma , protein kinase b , carcinogenesis , medicine , concomitant , pi3k/akt/mtor pathway , proportional hazards model , downregulation and upregulation , hazard ratio , cancer research , oncology , gastroenterology , pathology , cancer , biology , apoptosis , confidence interval , gene , biochemistry

14-3-3ζ is involved in the regulation of PI3K/Akt pathway which is closely associated with carcinogenesis. However, the clinical significance of combined detection of 14-3-3ζ and p-Akt in hepatocellular carcinoma (HCC) remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research